A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...
I’ve spent my life navigating cystic fibrosis alongside anxiety, OCD, and depression — struggles that once led me to numb everything with alcohol until a wake‑up call changed everything. Through ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...
The FDA has expanded indications for two targeted combination treatments, Alyftrek and Trikafta, that will now benefit more individuals with cystic fibrosis, according to a press release from the ...
Managing expectations about the future and enjoying the responsibility and fulfilment of being a parent is now to the ...
The text messages motivate Christian Collins to keep inspiring others. One told the USC-bound forward about three family ...
About Sionna Therapeutics Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel ...
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results